BioCentury | Oct 3, 2020
Politics, Policy & Law

Congressional Democrats rehearse drug pricing attacks

...Inc. (NASDAQ:AMGN), Bristol Myers Squibb Co. (NYSE:BMY), Mallinckrodt plc...
...part of BMS.The leaders of Amgen, BMS, Mallinckrodt...
...Children for Price Abuses” and “House Committee Targets Mallinckrodt...
BioCentury | Oct 1, 2020
Politics, Policy & Law

House committee targets Mallinckrodt, Amgen and Novartis over price increases

...on three drugs: H.P. Acthar Gel from Mallinckrodt plc...
...the price to $31,000 per vial. Since Mallinckrodt...
...billion. Mark Trudeau, president and CEO of Mallinckrodt...
BioCentury | Oct 1, 2020
Politics, Policy & Law

Revlimid, Copaxone are poster children for price abuses, House committee says

...Amgen Inc. (NASDAQ:AMGN); Mark Trudeau, CEO of Mallinckrodt plc...
BioCentury | Aug 7, 2020
Finance

Aug. 6 Quick Takes: More pressure on China’s U.S. listings; busy Editas; Athenex bestows royalty on Sagard; Longwood, CFF launch incubator and more

...fund as well as future fund-raising rounds. Mallinckrodt mulling bankruptcy In its 2Q20 earnings report, Mallinckrodt plc...
BioCentury | Nov 26, 2019
Company News

After mid-decade makeover, Medicines Co. accepts Novartis' $9.7B bid on eve of inclisiran submission

...divested a series of marketed hemostasis, cardiovascular and infectious disease assets in separate transactions with Mallinckrodt plc...
BioCentury | Sep 28, 2019
Company News

Management tracks: Bourla to succeed Read as Pfizer chair; plus Phathom, OnKure, Forma, Beam, Noven, Cerebral, Alpha Tau and InsightRX

...Foster as president and COO. He founded and was CEO of CNS Therapeutics Inc., which Mallinckrodt plc...
BioCentury | Sep 13, 2019
Politics, Policy & Law

Another chance to renew the social contract

...Bayer USA; Giovanni Caforio, chairman and CEO, Bristol-Myers Squibb Co.; Mark Trudeau, president and CEO, Mallinckrodt...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Johnson & Johnson Inc. (NYSE:JNJ), New Brunswick, N.J. Mallinckrodt plc...
...New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Allergan plc Baxter International Inc. Bayer AG Bristol-Myers Squibb Co. Johnson & Johnson Mallinckrodt plc Pfizer...
BioCentury | Sep 5, 2019
Company News

Sept. 5 Company Quick Takes: Zafgen exploring alternatives; plus BridgeBio, Global Blood, Akouos, Mallinckrodt, uBiome

...last year (see "Sound Story" ). Mallinckrodt sinks after report suggests bankruptcy is an option Mallinckrodt plc...
...trial concerning its sale and marketing of opioids. The report, which cited undisclosed sources, said Mallinckrodt...
...Bonanos, Associate Editor voxelotor (GBT440) ZGN-1061 8VC Akouos Inc. Andreessen Horowitz BridgeBio Pharma Inc. Carolinas HealthCare System Case Western Reserve University Global Blood Therapeutics Inc. Mallinckrodt plc uBiome...
BioCentury | Aug 15, 2019
Clinical News

At last, a win for terlipressin -- and Mallinckrodt

...after being rebuffed by FDA and with a failed Phase III trial squeezed in between, Mallinckrodt’s...
...in the Phase III CONFIRM trial in 300 patients with hepatorenal syndrome Type I (HRS-1). Mallinckrodt plc...
...p=0.22). Mallinckrodt entered the picture in 2015 when it acquired Ikaria for $2.3 billion (see "Mallinckrodt...
BioCentury | Aug 2, 2019
Finance

Earnings on deck

...NYSE:BHC) 8/6 Pre $1.05 $0.93 13% Endo International plc (NASDAQ:ENDP) 8/6 Pre $0.48 $0.76 -37% Mallinckrodt plc...
Items per page:
1 - 10 of 285
BioCentury | Oct 3, 2020
Politics, Policy & Law

Congressional Democrats rehearse drug pricing attacks

...Inc. (NASDAQ:AMGN), Bristol Myers Squibb Co. (NYSE:BMY), Mallinckrodt plc...
...part of BMS.The leaders of Amgen, BMS, Mallinckrodt...
...Children for Price Abuses” and “House Committee Targets Mallinckrodt...
BioCentury | Oct 1, 2020
Politics, Policy & Law

House committee targets Mallinckrodt, Amgen and Novartis over price increases

...on three drugs: H.P. Acthar Gel from Mallinckrodt plc...
...the price to $31,000 per vial. Since Mallinckrodt...
...billion. Mark Trudeau, president and CEO of Mallinckrodt...
BioCentury | Oct 1, 2020
Politics, Policy & Law

Revlimid, Copaxone are poster children for price abuses, House committee says

...Amgen Inc. (NASDAQ:AMGN); Mark Trudeau, CEO of Mallinckrodt plc...
BioCentury | Aug 7, 2020
Finance

Aug. 6 Quick Takes: More pressure on China’s U.S. listings; busy Editas; Athenex bestows royalty on Sagard; Longwood, CFF launch incubator and more

...fund as well as future fund-raising rounds. Mallinckrodt mulling bankruptcy In its 2Q20 earnings report, Mallinckrodt plc...
BioCentury | Nov 26, 2019
Company News

After mid-decade makeover, Medicines Co. accepts Novartis' $9.7B bid on eve of inclisiran submission

...divested a series of marketed hemostasis, cardiovascular and infectious disease assets in separate transactions with Mallinckrodt plc...
BioCentury | Sep 28, 2019
Company News

Management tracks: Bourla to succeed Read as Pfizer chair; plus Phathom, OnKure, Forma, Beam, Noven, Cerebral, Alpha Tau and InsightRX

...Foster as president and COO. He founded and was CEO of CNS Therapeutics Inc., which Mallinckrodt plc...
BioCentury | Sep 13, 2019
Politics, Policy & Law

Another chance to renew the social contract

...Bayer USA; Giovanni Caforio, chairman and CEO, Bristol-Myers Squibb Co.; Mark Trudeau, president and CEO, Mallinckrodt...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Johnson & Johnson Inc. (NYSE:JNJ), New Brunswick, N.J. Mallinckrodt plc...
...New York, N.Y. Steve Usdin, Washington Editor Abbott Laboratories AbbVie Inc. Allergan plc Baxter International Inc. Bayer AG Bristol-Myers Squibb Co. Johnson & Johnson Mallinckrodt plc Pfizer...
BioCentury | Sep 5, 2019
Company News

Sept. 5 Company Quick Takes: Zafgen exploring alternatives; plus BridgeBio, Global Blood, Akouos, Mallinckrodt, uBiome

...last year (see "Sound Story" ). Mallinckrodt sinks after report suggests bankruptcy is an option Mallinckrodt plc...
...trial concerning its sale and marketing of opioids. The report, which cited undisclosed sources, said Mallinckrodt...
...Bonanos, Associate Editor voxelotor (GBT440) ZGN-1061 8VC Akouos Inc. Andreessen Horowitz BridgeBio Pharma Inc. Carolinas HealthCare System Case Western Reserve University Global Blood Therapeutics Inc. Mallinckrodt plc uBiome...
BioCentury | Aug 15, 2019
Clinical News

At last, a win for terlipressin -- and Mallinckrodt

...after being rebuffed by FDA and with a failed Phase III trial squeezed in between, Mallinckrodt’s...
...in the Phase III CONFIRM trial in 300 patients with hepatorenal syndrome Type I (HRS-1). Mallinckrodt plc...
...p=0.22). Mallinckrodt entered the picture in 2015 when it acquired Ikaria for $2.3 billion (see "Mallinckrodt...
BioCentury | Aug 2, 2019
Finance

Earnings on deck

...NYSE:BHC) 8/6 Pre $1.05 $0.93 13% Endo International plc (NASDAQ:ENDP) 8/6 Pre $0.48 $0.76 -37% Mallinckrodt plc...
Items per page:
1 - 10 of 285